With eight candidates in human trials and almost 180 more in the wings, publications and press briefings touting progress are imminent. Here’s what to keep in mind as you decipher the results.
Category: pharma & healthcare
What Does Disappearing Immunity To Covid-19 Mean For A Vaccine?
Studies show that immunity to Covid-19 may fade quickly. Does this impact our ability to develop a successful vaccine?
The Complex, Global Evolution Of Coronavirus Mask Rules
Wearing masks won’t be a cure-all. But, if done in concert with other measures, mask-wearing may help curb the upward trend in new infections. And for this there appears to be a growing consensus based on guidance issued by most public health agencies …
80% Of People Hospitalized With Coronavirus Still Had Symptoms Two Months Later, Says New Study
Growing evidence suggests that the coronavirus can cause long-term symptoms in some people.
Is It Too Soon To Restart Sports?
Athletes and fans alike are itching to get back on the field and into the stadium. But so far, attempts to keep sports teams social distancing and safe are falling short.
Is Wearable Technology The Savior We’ve Been Waiting For?
The companies behind our favorite smart rings and wristwatches are trying to program their products to detect early symptoms of Covid-19. Could this help us stop its spread?
Brain Damage And Hallucinations Associated With Even Mild Covid-19 Coronavirus Infection
One woman hallucinated, reporting seeing lions and monkeys in her house. Another had to have part of her skull surgically removed to relieve brain swelling.
Trump Formally Moves To Sever Ties With WHO: Political Stunt?
This appears to be a political stunt, however, a strategy adopted by the Trump Administration to place blame for the Covid-19 crisis – what the president calls the “invisible enemy” – on foreign elements, such as the Chinese Communist Party, and intern…
Unique Agreement Calls For Health Insurers To Pay Hospitals For Their Covid-19 Losses
With this agreement private health insurers assert they ate “serving the interests of hospitals and insured beneficiaries.” Indeed, insurers are, by doing something unique, paying for care that hasn’t been provided to allow hospitals to stay afloat. …
Federal Appeals Court Blocks Launch Of Biosimilar Erelzi
Having de facto perpetual monopolies of originator biologics is not sustainable in an optimally functioning market. A balance needs to be struck between maintaining incentives for R&D of innovator biologics, allowing for biosimilar entry, and improving…
